XML 89 R16.htm IDEA: XBRL DOCUMENT
v3.24.1

Employee Stock Compensation Plans | 12 Months Ended
--- | ---
Dec. 31, 2023
Employee Stock Compensation Plans |
Employee Stock Compensation Plans | 10. Employee Stock Compensation Plans: On June 18, 2013, Solitario’s shareholders approved the 2013 Solitario Exploration & Royalty Corp. Omnibus Stock and Incentive Plan, as amended (the “2013 Plan”), which expired in April 2023. Under the terms of the 2013 Plan, a total of 5,750,000 shares of Solitario common stock are reserved for awards to directors, officers, employees and consultants. The 2013 plan permitted the Board of Directors of the Company (the “Board of Directors”) or a committee appointed by the Board of Directors to grant awards in the form of stock options, stock appreciation rights, restricted stock, and restricted stock units. As of December 31, 2023, the 2013 Plan has expired and no additional awards may be granted under the 2013 Plan, although awards made prior to the 2013 Plan’s expiration will remain outstanding in accordance with their terms. The outstanding awards under the 2013 Plan are detailed below. On June 20, 2023, Solitario’s shareholders approved the 2023 Solitario Stock and Incentive Plan (the “2023 Plan”). Under the terms of the 2023 Plan, a total of 5,000,000 shares of Solitario common stock are reserved for awards to directors, officers, employees and consultants. Awards may take the form of stock options, stock appreciation rights, restricted stock and restricted stock units. The terms and conditions of the awards are pursuant to the 2023 Plan and are granted by the Board of Directors or a committee appointed by the Board of Directors. The 2023 Plan has a term of 10 years. As of December 31, 2023, awards for a total of 50,000 options have been granted under the 2023 Plan. a.) Stock option grants The following table shows the grant date fair value of Solitario’s awards during 2023 and 2022 pursuant to the 2013 Plan and the 2023 Plan:
Grant Date |  | 11/16/23 (1) |  |  | 9/8/22 (1) |
Plan |  | 2023 Plan |  |  | 2013 Plan |
Option – grant date price |  | $ | 0.51 |  |  | $ | 0.60 |
Options granted |  |  | 50,000 |  |  |  | 2,360,000 |
Expected life years |  |  | 5.0 |  |  |  | 5.0 |
Expected volatility |  |  | 72 | % |  |  | 73 | %
Risk free interest rate |  |  | 4.4 | % |  |  | 3.4 | %
Weighted average fair value |  | $ | 0.32 |  |  | $ | 0.37 |
Grant date fair value |  | $ | 16,000 |  |  | $ | 876,000 |
| (1) | Option grants have a five-year term, and vest 25% on date of grant and 25% on each of the next three anniversary dates.
b.) Stock option activity During 2023 and 2022, options for 1,486,500 and 114,250, respectively, shares of common stock were exercised for proceeds of $459,315 and $30,000 respectively. The following table summarizes the activity for stock options outstanding under the 2023 Plan and the 2013 Plan for the years ended December 31, 2023 and 2022:
|  | 2023 |  |  | 2022 |
|  |  |  |  | Weighted |  |  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  | Average |  |  | Aggregate |  |  |  |  |  | Average |  |  | Aggregate |
|  |  |  |  | Exercise |  |  | Intrinsic |  |  |  |  |  | Exercise |  |  | Intrinsic |
|  | Options |  |  | Price |  |  | Value (1)(2) |  |  | Options |  |  | Price |  |  | Value (1)(2) |
Outstanding, beginning of year |  |  | 5,390,000 |  |  | $ | 0.42 |  |  |  |  |  |  | 5,513,000 |  |  | $ | 0.49 |  |  |  |
Granted |  |  | 50,000 |  |  | $ | 0.51 |  |  |  |  |  |  | 2,360,000 |  |  | $ | 0.60 |  |  |  |
Exercised |  |  | (1,486,500 | ) |  | $ | 0.31 |  |  | $ | 338,000 |  |  |  | (114,250 | ) |  | $ | 0.26 |  |  |  |
Expired |  |  | - |  |  |  |  |  |  |  |  |  |  |  | (2,360,000 | ) |  | $ | 0.77 |  |  |  |
Forfeited |  |  | (125,000 | ) |  | $ | 0.31 |  |  |  |  |  |  |  | (8,750 | ) |  | $ | 0.20 |  |  |  |
Outstanding, end of year |  |  | 3,828,500 |  |  | $ | 0.47 |  |  | $ | 1,034,000 |  |  |  | 5,390,000 |  |  | $ | 0.42 |  |  | $ | 1,034,000 |
Exercisable, end of year |  |  | 2,576,000 |  |  | $ | 0.41 |  |  | $ | 899,000 |  |  |  | 3,227,500 |  |  | $ | 0.34 |  |  | $ | 899,000 |
| (1) | Intrinsic value based upon December 31, 2023 and 2022 price of a share of Solitario common stock as quoted on the NYSE American exchange of $0.56 and $0.62, respectively, per share.
| (2) | For options exercised during 2023 the intrinsic value based upon the price of a share of Solitario common stock as quoted on the NYSE American on the date of exercise of each option.
During the years ended December 31, 2023 and 2022, Solitario recorded $247,000 and $338,000, respectively, of stock-based compensation expense under the 2023 Plan and the 2013 Plan for the amortization of the grant date fair value of each of its outstanding options with a credit to additional paid-in-capital. At December 31, 2023, the total unrecognized stock option compensation cost related to non-vested options is $387,000 and is expected to be recognized over a weighted average period of 20 months. At December 31, 2023, the average remaining contractual life of Solitario’s outstanding options is 2.9 years. At December 31, 2023, the average remaining contractual life of Solitario’s vested options is 2.4 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration